Meeting Highlights: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005
Open accessThe DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., van 't Veer, L. J., Dai, H., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,488
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
Paik, S., Shak, S., Tang, G., Kim, C., Baker, J., Cronin, M., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,277
Repeated observation of breast tumor subtypes in independent gene expression data sets
Sørlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J. S., Nobel, A., Deng, S., Johnsen, H., Pesich, R., Geisler, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,429
Tamoxifen for early breast cancer: an overview of the randomised trials
(1998) · The Lancet · doi:10.1016/s0140-6736(97)11423-4 · Cited by 4,085
Focan, C., Steinberg, S. M., Blichert-Toft, M., Forbes, J., Collins, R. D., Anderson, S., Margreiter, R., Harwood, C. S., Andersen, K., Beighton, G., et al. (1998) · PubMed · Cited by 2,146
Self-citationPrognostic and predictive factors in breast cancer by immunohistochemical analysis.
Allred, D. C., Harvey, J. M., Berardo, M. D., & Gm, C. (1998) · PubMed · Cited by 2,143
Harvey, J. M., Clark, G. M., Osborne, C. K., & Allred, D. C. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.5.1474 · Cited by 2,056
Sotiriou, C., Neo, S.-Y., McShane, L. M., Korn, E. L., Long, P. M., Jazaeri, A., Martiat, P., Fox, S. B., Harris, A. L., & Liu, E. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1732912100 · Cited by 1,993
Goss, P. E., Ingle, J. N., Martino, S., Robert, N. J., Muss, H. B., Piccart, M. J., Castiglione, M., Tu, D., Shepherd, L. E., Pritchard, K. I., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa032312 · Cited by 1,795
Coombes, R. C., Hall, E., Gibson, L. J., Paridaens, R., Jassem, J., Delozier, T., Jones, S. E., Alvarez, I., Bertelli, G., Ortmann, O., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040331 · Cited by 1,759
Self-citationKriege, M., Brekelmans, C. T. M., Boetes, C., Besnard, P. E., Zonderland, H. M., Obdeijn, I. M., Manoliu, R. A., Kok, T., Peterse, H., Tilanus-Linthorst, M. M. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031759 · Cited by 1,687
Citron, M. L., Berry, D. A., Cirrincione, C., Hudis, C., Winer, E. P., Gradishar, W. J., Davidson, N. E., Martino, S., Livingston, R., Ingle, J. N., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.09.081 · Cited by 1,564
Prophylactic Oophorectomy in Carriers of BRCA1 or BRCA2 Mutations
Rebbeck, T. R., Lynch, H. T., Neuhausen, S. L., Narod, S. A., van't Veer, L., Garber, J. E., Evans, G., Isaacs, C., Daly, M. B., Matloff, E., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012158 · Cited by 1,465
The anti-angiogenic basis of metronomic chemotherapy
Kerbel, R. S., & Kamen, B. A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1369 · Cited by 1,397
Miller, K. D., Chap, L. I., Holmes, F. A., Cobleigh, M. A., Marcom, P. K., Fehrenbacher, L., Dickler, M., Overmoyer, B. A., Reimann, J. D., Sing, A. P., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.098 · Cited by 1,306
Cancer incidence and mortality in Europe, 2004
Boyle, P., & Ferlay, J. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi098 · Cited by 1,217
Rebbeck, T. R., Friebel, T., Lynch, H. T., Neuhausen, S. L., van ’t Veer, L., Garber, J. E., Evans, G. R., Narod, S. A., Isaacs, C., Matloff, E., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.188 · Cited by 1,171 · cited 1×
“BRCA1 and BRCA2 mutation carriers benefit from prophylactic strategies including bilateral oophorectomy [10, 11], bilateral mastectomy with reconstruction [12] and chemoprevention, while the role of intensified surveillance is controversial [13].”
BackgroundBuzdar, A. U., Ibrahim, N. K., Francis, D., Booser, D. J., Thomas, E. S., Theriault, R. L., Pusztai, L., Green, M. C., Arun, B. K., Giordano, S. H., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.032 · Cited by 1,171
Shou, J., Massarweh, S., Osborne, C. K., Wakeling, A. E., Ali, S., Weiss, H., & Schiff, R. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh166 · Cited by 1,153
Hughes, K. S., Schnaper, L. A., Berry, D., Cirrincione, C., McCormick, B., Shank, B., Wheeler, J., Champion, L. A., Smith, T. J., Smith, B. L., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040587 · Cited by 1,078
Ellis, M. J., Coop, A., Singh, B., Mauriac, L., Llombert-Cussac, A., Jänicke, F., Miller, W. R., Evans, D. B., Dugan, M., Brady, C., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.18.3808 · Cited by 1,060
Winer, E. P., Hudis, C., Burstein, H. J., Wolff, A. C., Pritchard, K. I., Ingle, J. N., Chlebowski, R. T., Gelber, R., Edge, S. B., Gralow, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.121 · Cited by 1,031
Self-citationRagaz, J., Olivotto, I. A., Spinelli, J. J., Phillips, N., Jackson, S. M., Wilson, K. S., Knowling, M. A., Coppin, C. M. L., Weir, L., Gelmon, K., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh297 · Cited by 1,027
Cancer incidence and mortality in Europe
Levi, F., Maisonneuve, P., Filiberti, R., La Vecchia, C., & Boyle, P. (1989) · Sozial- und Präventivmedizin · doi:10.1007/bf02148558 · Cited by 968
Adjuvant Docetaxel for Node-Positive Breast Cancer
Martin, M., Pienkowski, T., Mackey, J., Pawlicki, M., Guastalla, J.-P., Weaver, C., Tomiak, E., Al-Tweigeri, T., Chap, L., Juhos, E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043681 · Cited by 954
Bartelink, H., Horiot, J.-C., Poortmans, P., Struikmans, H., Van den Bogaert, W., Barillot, I., Fourquet, A., Borger, J., Jager, J., Hoogenraad, W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010874 · Cited by 941
Self-renewal and solid tumor stem cells
Al-Hajj, M., & Clarke, M. F. (2004) · Oncogene · doi:10.1038/sj.onc.1207947 · Cited by 914
Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors
Minn, A. J., Kang, Y., Serganova, I. S., Gupta, G. P., Giri, D. D., Doubrovin, M., Ponomarev, V., Gerald, W. L., Blasberg, R. G., & Massagué, J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522320 · Cited by 742
Goldhirsch, A., Wood, W. C., Gelber, R. D., Coates, A. S., Thürlimann, B., & Senn, H.-J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.576 · Cited by 697
Self-citationHereditary Cancer Predisposition Syndromes
Garber, J. E., & Offit, K. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.042 · Cited by 697
Martino, S., Cauley, J. A., Barrett-Connor, E., Powles, T. J., Mershon, J., Disch, D., Secrest, R. J., Cummings, S. R., & For the CORE Investigators (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh319 · Cited by 684
Fyles, A. W., McCready, D. R., Manchul, L. A., Trudeau, M. E., Merante, P., Pintilie, M., Weir, L. M., & Olivotto, I. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040595 · Cited by 651
The HER-2/neu Gene and Protein in Breast Cancer 2003: Biomarker and Target of Therapy
Ross, J. S., Fletcher, J. A., Linette, G. P., Stec, J., Clark, E., Ayers, M., Symmans, W. F., Pusztai, L., & Bloom, K. J. (2003) · The Oncologist · doi:10.1634/theoncologist.8-4-307 · Cited by 610
Does Delay in Starting Treatment Affect the Outcomes of Radiotherapy? A Systematic Review
Huang, J., Barbera, L., Brouwers, M., Browman, G., & Mackillop, W. J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.171 · Cited by 586
Ovarian ablation in early breast cancer: overview of the randomised trials
(1996) · The Lancet · doi:10.1016/s0140-6736(96)05023-4 · Cited by 561
Gennari, R., Menard, S., Fagnoni, F., Ponchio, L., Scelsi, M., Tagliabue, E., Castiglioni, F., Villani, L., Magalotti, C., Gibelli, N., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0225 · Cited by 516
Klijn, J. G. M., Blamey, R. W., Boccardo, F., Tominaga, T., Duchateau, L., & Sylvester, R. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.343 · Cited by 425
Breast Conservation After Neoadjuvant Chemotherapy: The M.D. Anderson Cancer Center Experience
Chen, A. M., Meric‐Bernstam, F., Hunt, K. K., Thames, H. D., Oswald, M. J., Outlaw, E. D., Strom, E. A., McNeese, M. D., Kuerer, H. M., Ross, M. I., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.09.062 · Cited by 411
Foulkes, W. D., Brunet, J.-S., Stefansson, I. M., Straume, O., Chappuis, P. O., Bégin, L. R., Hamel, N., Goffin, J. R., Wong, N., Trudel, M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2970 · Cited by 363
BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells
Tassone, P., Tagliaferri, P., Perricelli, A., Blotta, S., Quaresima, B., Martelli, M. L., Goel, A., Barbieri, V, Costanzo, F., Boland, C. R., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600859 · Cited by 361
Colleoni, M., Viale, G., Zahrieh, D., Pruneri, G., Gentilini, O., Veronesi, P., Gelber, R. D., Curigliano, G., Torrisi, R., Luini, A., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0380 · Cited by 353
Self-citationBergh, J., Wiklund, T., Erikstein, B., Lidbrink, E., Lindman, H., Malmström, P., Kellokumpu-Lehtinen, P., Bengtsson, N.-O., Söderlund, G., Anker, G., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02841-5 · Cited by 339
PINDER, S. E., ELLIS, I. O., GALEA, M., O'ROUKE, S., BLAMEY, R. W., & ELSTON, C. W. (1994) · Histopathology · doi:10.1111/j.1365-2559.1994.tb01269.x · Cited by 287
Prognostic Value of Lymphangiogenesis and Lymphovascular Invasion in Invasive Breast Cancer
Schoppmann, S. F., Bayer, G., Aumayr, K., Taucher, S., Geleff, S., Rudas, M., Kubista, E., Hausmaninger, H., Samonigg, H., Gnant, M., et al. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000133355.48672.22 · Cited by 281
Cserni, G., Gregori, D., Merletti, F., Sapino, A., Mano, M. P., Ponti, A., Sandrucci, S., Baltás, B., & Bussolati, G. (2004) · British Journal of Surgery · doi:10.1002/bjs.4725 · Cited by 280
Burstein, H. J., Harris, L. N., Gelman, R., Lester, S. C., Nunes, R. A., Kaelin, C. M., Parker, L. M., Ellisen, L. W., Kuter, I., Gadd, M. A., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.124 · Cited by 280
International Breast Cancer Study Group (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg119 · Cited by 264
30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study
Bonadonna, G., Moliterni, A., Zambetti, M., Daidone, M. G., Pilotti, S., Gianni, L., & Valagussa, P. (2005) · BMJ · doi:10.1136/bmj.38314.622095.8f · Cited by 252
Therasse, P., Mauriac, L., Welnicka-Jaskiewicz, M., Bruning, P., Cufer, T., Bonnefoi, H., Tomiak, E., Pritchard, K. I., Hamilton, A., & Piccart, M. J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.135 · Cited by 224
Colleoni, M., Bonetti, M., Coates, A. S., Castiglione-Gertsch, M., Gelber, R. D., Price, K., Rudenstam, C.-M., Lindtner, J., Collins, J., Thürlimann, B., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.3.584 · Cited by 197
Self-citationWiedswang, G., Borgen, E., Kåresen, R., Qvist, H., Janbu, J., Kvalheim, G., Nesland, J. M., & Naume, B. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0245 · Cited by 185
Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer
International Breast Cancer Study Group, Hürny, C., Bernhard, J., Castiglione-Gertsch, M., Coates, A. S., Peterson, H. F., Gelber, R. D., Forbes, J. F., Rudenstam, C.-M., Simoncini, E., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90936-8 · Cited by 171
Self-citationDAVIES, C. (2004) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(04)00121-5 · Cited by 170
Colleoni, M., Rotmensz, N., Peruzzotti, G., Maisonneuve, P., Mazzarol, G., Pruneri, G., Luini, A., Intra, M., Veronesi, P., Galimberti, V., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.094 · Cited by 168
Self-citationSimon, M. S., Du, W., Flaherty, L., Philip, P. A., Lorusso, P., Miree, C., Smith, D., & Brown, D. R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.005 · Cited by 163
HER-2/neu Gene Amplification and Response to Paclitaxel in Patients With Metastatic Breast Cancer
Konecny, G., Thomssen, C., Lück, H., Untch, M., Wang, H.-J., Kuhn, W. C., Eidtmann, H., Bois, A. D., Olbricht, S., Steinfeld, D., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh198 · Cited by 156
Harris, E. E. R., Christensen, V. J., Hwang, W., Fox, K. R., & Solin, L. J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.056 · Cited by 128
Osborne, C. K., Schiff, R., Arpino, G., Lee, A. S., & Hilsenbeck, V. G. (2005) · The Breast · doi:10.1016/j.breast.2005.08.024 · Cited by 127
Serum HER-2/neu and Response to the Aromatase Inhibitor Letrozole Versus Tamoxifen
Lipton, A., Ali, S. M., Leitzel, K., Demers, L., Harvey, H. A., Chaudri‐Ross, H. A., Brady, C., Wyld, P. J., & Carney, W. P. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.09.098 · Cited by 124
Schwartz, M. D., Kaufman, E. A., Peshkin, B. N., Isaacs, C. J., Hughes, C., DeMarco, T. A., Finch, C., & Lerman, C. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.088 · Cited by 121
Duric, V. M., & Stockler, M. R. (2001) · The Lancet Oncology · doi:10.1016/s1470-2045(01)00559-9 · Cited by 119
Fargeot, P., Bonneterre, J. M., Roche, H. H., Lortholary, A. H., Campone, M., Praagh, I. V., Monnier, A., Namer, M., Schraub, S., Barats, J. C., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.145 · Cited by 111
Prognostic and predictive factors revisited
Hayes, D. F. (2005) · The Breast · doi:10.1016/j.breast.2005.08.023 · Cited by 107
de Mascarel, I., Bonichon, F., Durand, M., Mauriac, L., MacGrogan, G. M., Soubeyran, I., Picot, V., Avril, A., Coindre, J., & Trojani, M. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00344-4 · Cited by 97
Boccardo, F., RUBAGOTTI, A., AMOROSO, D., Mesiti, M., Romeo, D., Caroti, C., Farris, A., Cruciani, G., Villa, E., Schieppati, G., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.22.4209 · Cited by 86
Adjuvant Endocrine Therapy for Premenopausal Women With Early Breast Cancer
Dellapasqua, S., Colleoni, M. A., Gelber, R. D., & Goldhirsch, A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.11.050 · Cited by 84
Self-citationFisher, B., Jeong, J., Anderson, S., & Wolmark, N. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh338 · Cited by 83
Treatment of Breast Cancer in Countries with Limited Resources
Carlson, R. W., Anderson, B. O., Chopra, R., Eniu, A. E., Jakesz, R., Love, R. R., Masetti, R., & Schwartsmann, G. (2003) · The Breast Journal · doi:10.1046/j.1524-4741.9.s2.6.x · Cited by 83
Wallner, P. E., Arthur, D. W., Bartelink, H. G. M. M., Connolly, J. L., Edmundson, G., Giuliano, A. E., Goldstein, N. S., Hevezi, J. M., Julian, T. B., Kuske, R. R., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh023 · Cited by 78
Urokinase-Type Plasminogen Activator System in Breast Cancer
Gelder, M. E. M., Look, M. P., Peters, H. A., Schmitt, M., Brünner, N., Harbeck, N., Klijn, J. G. M., & Foekens, J. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3848 · Cited by 70
Increased p53 mutation frequency during tumor progression--results from a breast cancer cohort.
Norberg, T., Klaar, S., Kärf, G., et al. (2001) · PubMed · Cited by 52
Acceptance of adjuvant therapy and quality of life issues
Fallowfield, L. (2005) · The Breast · doi:10.1016/j.breast.2005.08.012 · Cited by 52
Trastuzumab Plus Tamoxifen: Anti-Proliferative and Molecular Interactions in Breast Carcinoma
Ropero, S., Menéndez, J. A., Vázquez‐Martín, A., Montero, S., Cortés-Funes, H., & Colomer, R. (2004) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000032981.20384.c6 · Cited by 47
Ovarian Ablation as Adjuvant Therapy for Breast Cancer
Davidson, N. E. (2001) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a003464 · Cited by 47
Prowell, T. M., & Davidson, N. E. (2004) · The Oncologist · doi:10.1634/theoncologist.9-5-507 · Cited by 36
Myth-Busters: Telling the True Story of Breast Cancer Survivorship
Schover, L. R. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh346 · Cited by 31
Serum HER-2/neu and response to the aromatase inhibitor letrozole versus tamoxifen
Lipton, A., Mouridsen, H. T., Ali, S.-A. M., et al. (2001) · Breast Diseases A Year Book Quarterly · Cited by 22
Studts, J. L., Abell, T. D., Roetzer, L. M., Albers, A., McMasters, K. M., & Chao, C. (2004) · Psycho-Oncology · doi:10.1002/pon.886 · Cited by 20
Biological variables and prognosis of DCIS
van de Vijver, M. J. (2005) · The Breast · doi:10.1016/j.breast.2005.08.027 · Cited by 20
Treatment of breast cancer with aromatase inhibitors – current status and future prospects
Lønning, P. E., Dowsett, M., & Powles, T. (1989) · British Journal of Cancer · doi:10.1038/bjc.1989.208 · Cited by 18
Adjuvant Therapy in Elderly Patients with Breast Cancer
Biganzoli, L., Aapro, M., Balducci, L., Crivellari, D., Minisini, A. M., & Piccart, M. J. (2004) · Clinical Breast Cancer · doi:10.3816/cbc.2004.n.022 · Cited by 17
Ravdin, P. M., & Davis, G. J. (2004) · Clinical Breast Cancer · doi:10.3816/cbc.2004.n.047 · Cited by 14
Truong, M. T., Hirsch, A. E., & Formenti, S. C. (2003) · Clinical Breast Cancer · doi:10.3816/cbc.2003.n.030 · Cited by 14
Peptide-Based Vaccines in Breast Cancer
Disis, M. L., Salazar, L. G., & Knutson, K. L. (2004) · Breast Disease · doi:10.3233/bd-2004-20102 · Cited by 12
Cited by
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
Wang, Y., Klijn, J. G., Zhang, Y., Sieuwerts, A. M., Look, M. P., Yang, F., Talantov, D., Timmermans, M., Meijer-van Gelder, M. E., Yu, J., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17947-1 · Cited by 2,846
A Comparison of Letrozole and Tamoxifen in Postmenopausal Women with Early Breast Cancer
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052258 · Cited by 1,577
Goldhirsch, A., Ingle, J. N., Gelber, R. D., Coates, A. S., Thürlimann, B., & Senn, H.-J. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp322 · Cited by 1,374
Self-citationBuyse, M., Loi, S., van't Veer, L., Viale, G., Delorenzi, M., Glas, A. M., Saghatchian d'Assignies, M., Bergh, J., Lidereau, R., Ellis, P., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj329 · Cited by 1,238
Galimberti, V., Cole, B. F., Zurrida, S., Viale, G., Luini, A., Veronesi, P., Baratella, P., Chifu, C., Sargenti, M., Intra, M., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70035-4 · Cited by 1,233
Self-citation
Metadata
- Authors
- Goldhirsch, A., Glick, J. H., Gelber, R. D., Coates, A. S., Thürlimann, B., & Senn, H.-J.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2005-10
- Volume
- 16
- Issue
- 10
- Pages
- 1569-1583
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2123129045
- Cited by
- 1,127
- References
- 87
- FWCI
- 56.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.